“Based on the available scientific evidence, the working group continues to support the use of this vaccine.
It significantly reduces the risk of serious illness and hospitalization associated with COVID-19 in all adults, ”RIA Novosti quotes a statement from the vaccination working group.
The Belgian national regulator - the Federal Agency for Medicines and Drugs for Health - said that as of March 8, more than 94,000 people had received the AstraZeneca vaccine.
At the same time, not a single case of thromboembolism was recorded.
Earlier, medical authorities in various European countries refused to use the AstraZeneca vaccine.
WHO experts are studying the situation.